Lakeshore Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Lakeshore Capital Group's LLY Position: Q1 2026 in Review
Lakeshore Capital Group increased its Eli Lilly (LLY) stake by 0.67% in Q1 2026, buying an estimated $7.1K and bringing the position to 1,059 shares worth $974K. The position accounts for 0.8% of the portfolio, ranked #42.
Lakeshore Capital Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.13M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Lakeshore Capital Group held 1,059 shares of Eli Lilly worth $974K as of Q1 2026.
- Lakeshore Capital Group bought 7 Eli Lilly shares in Q1 2026, an estimated $7.1K.
- Eli Lilly made up 0.8% of Lakeshore Capital Group's portfolio in Q1 2026, its #42 holding.
- Lakeshore Capital Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Lakeshore Capital Group's Eli Lilly position peaked at $1.13M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Lakeshore Capital Group's 13F filing for Q1 2026, filed 22 Apr 2026.